SCHEMBL8859528

SCHEMBL8859528

CCCCCOCCOCC(C)C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.52
MEN1 O00255 1/20 0.52
THRB P10828 1/20 0.52
KMT2A Q03164 1/20 0.52
MAPT P10636 1/20 0.52
USP2 O75604 1/20 0.50
SPHK1 Q9NYA1 1/20 0.48
PRKD3 O94806 1/20 0.43
PRKCG P05129 1/20 0.43
PRKCB P05771 1/20 0.43
PRKCA P17252 1/20 0.43
PRKCH P24723 1/20 0.43
PRKCI P41743 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCZ Q05513 1/20 0.43
PRKCD Q05655 1/20 0.43
PRKD1 Q15139 1/20 0.43
LPAR1 Q92633 7/20 0.42
LPAR3 Q9UBY5 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27892615 1.00 HTT (0.52) HTTMEN1THRBKMT2AMAPT
SCHEMBL15673495 0.98 HTT (0.56) HTTMEN1THRBKMT2AMAPT
SCHEMBL95514 0.98 USP2 (0.52) HTTMEN1THRBKMT2AMAPT
SCHEMBL96285 0.95 USP2 (0.54) HTTMEN1THRBKMT2AMAPT
SCHEMBL13315991 0.93 TSHR (0.48) HTTMEN1THRBKMT2AMAPT
SCHEMBL29030314 0.93 TSHR (0.48) HTTMEN1THRBKMT2AMAPT
SCHEMBL4489928 0.93 USP2 (0.57) HTTMEN1THRBKMT2AMAPT
SCHEMBL4483278 0.93 USP2 (0.57) HTTMEN1THRBKMT2AMAPT
SCHEMBL2766746 0.93 USP2 (0.57) HTTMEN1THRBKMT2AMAPT
SCHEMBL10151453 0.93 USP2 (0.57) HTTMEN1THRBKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102898149-A Solvent or solvent composition for manufacturing laminated ceramic member DAICEL CHEM 2013-01-30 CN disclosed
WO-1997031628-A1 PEPTIDOMIMETICS FOR THE TREATMENT OF HIV INFECTION INNAPHARMA, INC. (US) 1997-09-04 WO disclosed